Capital Point Ltd. - 14 Aug 2025 SCHEDULE 13G Report for Nasus Pharma Ltd. Ordinary Shares, no par value

Filing Manager: Capital Point Ltd.
Reporting Manager: Capital Point Ltd.
Security: Nasus Pharma Ltd. Ordinary Shares, no par value
Shares outstanding: 9.06M shares
Disclosed Ownership: 575K shares
Ownership: 6.35%
Form type: SCHEDULE 13G
Filing time: 20 Aug 2025, 16:55:04 UTC
Date of event: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Capital Point Ltd.	6.35%	575K	575K	0	/s/ Avi Katzav	Chief Financial Officer